HLN · Haleon plc ADR
United States · RS rating 44 · As of 2026-11-03
| Price | 8.84 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 57 / 44 / 48 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 42 / 26 / 12 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.8% |
| Distance from 52-week high | +21.6% |
| Market cap (USD) | $42.4B |